EarningsNxt
CalendarInsightsFor AgentsAbout
EarningsNxt

Earnings briefings in plain English, before and after the bell. Free calendar, Pro briefs at $8/mo.

Get briefs in your inbox For agents

Popular tickers

AAPLMSFTGOOGLAMZNNVDAMETATSLAJPMVUNHJNJWMT

Product

  • Earnings Calendar
  • Pricing
  • For Agents

Resources

  • Insights
  • API Reference
  • FAQ
  • llms.txt

Company

  • About
  • Contact
  • X / Twitter
  • StockTwits
  • Instagram

© 2026 EarningsNxt. For informational purposes only. Not financial advice. AI-assisted content may contain errors.

Terms of ServicePrivacy PolicyDisclaimerDisclosureAccessibilityDo Not Sell My Info
  1. Home
  2. LGND

Equity Profile

LGND

Ligand Pharmaceuticals Incorporated

Health CarePharmaceuticals$5.9B market cap

Earnings scorecard

Last 76Q

EPS beat streak

11Q

EPS beat rate

75%

Avg EPS surprise

+120.25%

Avg 1-day reaction

+0.92%

Earnings history

77 quarters
Full history
QuarterReportedEst.ActualSurprise1-day
Q3-2026UpcomingNov 5, 2026————Preview
Q2-2026Aug 6, 2026$1.34$2.37+76.87%-0.80%Preview
Q1-2026May 7, 2026$1.84$1.63+66.84%-9.55%Preview
Q4-2025Feb 26, 2026$0.63$2.02+219.62%+2.50%Preview
Q3-2025Nov 6, 2025$1.08$3.09+184.79%+9.37%Preview
Q2-2025Aug 7, 2025ProPreview
Q1-2025May 8, 2025ProPreview
Q4-2024Feb 27, 2025ProPreview
Q3-2024Nov 7, 2024ProPreview
Q2-2024Aug 6, 2024ProPreview
Q1-2024May 7, 2024ProPreview
Q4-2023Feb 27, 2024ProPreview
Q3-2023Nov 8, 2023ProPreview
Q2-2023Aug 8, 2023ProPreview
Q1-2023May 4, 2023ProPreview
Q4-2022Feb 22, 2023ProPreview
Q3-2022Nov 7, 2022ProPreview
Q2-2022Aug 8, 2022ProPreview
Q1-2022May 4, 2022ProPreview
Q4-2021Feb 17, 2022ProPreview
Q3-2021Nov 9, 2021ProPreview
Q2-2021Jul 29, 2021ProPreview
Q1-2021May 3, 2021ProPreview
Q4-2020Feb 3, 2021ProPreview
Q3-2020Oct 30, 2020ProPreview
Q2-2020Aug 3, 2020ProPreview
Q1-2020May 6, 2020ProPreview
Q4-2019Feb 6, 2020ProPreview
Q3-2019Nov 5, 2019ProPreview
Q2-2019Jul 30, 2019ProPreview
Q1-2019May 2, 2019ProPreview
Q4-2018Feb 7, 2019ProPreview
Q3-2018Nov 8, 2018ProPreview
Q2-2018Aug 6, 2018ProPreview
Q1-2018May 8, 2018ProPreview
Q4-2017Feb 21, 2018ProPreview
Q3-2017Nov 9, 2017ProPreview
Q2-2017Aug 7, 2017ProPreview
Q1-2017May 9, 2017ProPreview
Q4-2016Feb 23, 2017ProPreview
Q3-2016Nov 3, 2016ProPreview
Q2-2016Aug 4, 2016ProPreview
Q1-2016May 4, 2016ProPreview
Q4-2015Feb 10, 2016ProPreview
Q3-2015Nov 9, 2015ProPreview
Q2-2015Aug 4, 2015ProPreview
Q1-2015May 11, 2015ProPreview
Q4-2014Feb 9, 2015ProPreview
Q3-2014Oct 27, 2014ProPreview
Q2-2014Aug 4, 2014ProPreview
Q1-2014May 7, 2014ProPreview
Q4-2013Feb 11, 2014ProPreview
Q3-2013Oct 30, 2013ProPreview
Q2-2013Aug 1, 2013ProPreview
Q1-2013May 8, 2013ProPreview
Q4-2012Feb 13, 2013ProPreview
Q3-2012Nov 5, 2012ProPreview
Q2-2012Aug 8, 2012ProPreview
Q1-2012May 2, 2012ProPreview
Q4-2011Feb 7, 2012ProPreview
Q3-2011Nov 8, 2011ProPreview
Q2-2011Aug 8, 2011ProPreview
Q1-2011May 10, 2011ProPreview
Q4-2010Feb 15, 2011ProPreview
Q3-2010Nov 9, 2010ProPreview
Q2-2010Aug 5, 2010ProPreview
Q1-2010May 5, 2010ProPreview
Q4-2009Feb 9, 2010ProPreview
Q3-2009Nov 5, 2009ProPreview
Q2-2009Aug 3, 2009ProPreview
Q1-2009May 6, 2009ProPreview
Q4-2008Feb 12, 2009ProPreview
Q3-2008Nov 6, 2008ProPreview
Q2-2008Jul 31, 2008ProPreview
Q1-2008May 1, 2008ProPreview
Q4-2007Feb 20, 2008ProPreview
Q3-2007Nov 8, 2007ProPreview

Next report

Q3-2026

Thu, Nov 5

Before the open

Est. EPS

—

Est. Rev

—

Read the preview

About LGND

Sector
Health Care
Industry
Pharmaceuticals
Market cap
$5.9B

72 earlier quarters of EPS results and stock reactions are part of Pro.

No charge today · $8/mo after 7 days · Cancel anytime

Q2-2025Aug 7, 2025ProPreview
Q1-2025May 8, 2025ProPreview
Q4-2024Feb 27, 2025Pro
Preview
Q3-2024Nov 7, 2024ProPreview
Q2-2024Aug 6, 2024ProPreview
Q1-2024May 7, 2024ProPreview
Q4-2023Feb 27, 2024ProPreview
Q3-2023Nov 8, 2023ProPreview
Q2-2023Aug 8, 2023ProPreview
Q1-2023May 4, 2023ProPreview
Q4-2022Feb 22, 2023ProPreview
Q3-2022Nov 7, 2022ProPreview
Q2-2022Aug 8, 2022ProPreview
Q1-2022May 4, 2022ProPreview
Q4-2021Feb 17, 2022ProPreview
Q3-2021Nov 9, 2021ProPreview
Q2-2021Jul 29, 2021ProPreview
Q1-2021May 3, 2021ProPreview
Q4-2020Feb 3, 2021ProPreview
Q3-2020Oct 30, 2020ProPreview
Q2-2020Aug 3, 2020ProPreview
Q1-2020May 6, 2020ProPreview
Q4-2019Feb 6, 2020ProPreview
Q3-2019Nov 5, 2019ProPreview
Q2-2019Jul 30, 2019ProPreview
Q1-2019May 2, 2019ProPreview
Q4-2018Feb 7, 2019ProPreview
Q3-2018Nov 8, 2018ProPreview
Q2-2018Aug 6, 2018ProPreview
Q1-2018May 8, 2018ProPreview
Q4-2017Feb 21, 2018ProPreview
Q3-2017Nov 9, 2017ProPreview
Q2-2017Aug 7, 2017ProPreview
Q1-2017May 9, 2017ProPreview
Q4-2016Feb 23, 2017ProPreview
Q3-2016Nov 3, 2016ProPreview
Q2-2016Aug 4, 2016ProPreview
Q1-2016May 4, 2016ProPreview
Q4-2015Feb 10, 2016ProPreview
Q3-2015Nov 9, 2015ProPreview
Q2-2015Aug 4, 2015ProPreview
Q1-2015May 11, 2015ProPreview
Q4-2014Feb 9, 2015ProPreview
Q3-2014Oct 27, 2014ProPreview
Q2-2014Aug 4, 2014ProPreview
Q1-2014May 7, 2014ProPreview
Q4-2013Feb 11, 2014ProPreview
Q3-2013Oct 30, 2013ProPreview
Q2-2013Aug 1, 2013ProPreview
Q1-2013May 8, 2013ProPreview
Q4-2012Feb 13, 2013ProPreview
Q3-2012Nov 5, 2012ProPreview
Q2-2012Aug 8, 2012ProPreview
Q1-2012May 2, 2012ProPreview
Q4-2011Feb 7, 2012ProPreview
Q3-2011Nov 8, 2011ProPreview
Q2-2011Aug 8, 2011ProPreview
Q1-2011May 10, 2011ProPreview
Q4-2010Feb 15, 2011ProPreview
Q3-2010Nov 9, 2010ProPreview
Q2-2010Aug 5, 2010ProPreview
Q1-2010May 5, 2010ProPreview
Q4-2009Feb 9, 2010ProPreview
Q3-2009Nov 5, 2009ProPreview
Q2-2009Aug 3, 2009ProPreview
Q1-2009May 6, 2009ProPreview
Q4-2008Feb 12, 2009ProPreview
Q3-2008Nov 6, 2008ProPreview
Q2-2008Jul 31, 2008ProPreview
Q1-2008May 1, 2008ProPreview
Q4-2007Feb 20, 2008ProPreview
Q3-2007Nov 8, 2007ProPreview